Simplify Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,618
Closed -$609K 122
2024
Q3
$609K Buy
7,618
+3,068
+67% +$231K 0.03% 85
2024
Q2
$326K Sell
4,550
-4,602
-50% -$339K 0.02% 97
2024
Q1
$644K Buy
9,152
+4,888
+115% +$350K 0.04% 82
2023
Q4
$329K Sell
4,264
-312
-7% -$20.6K 0.03% 100
2023
Q3
$311K Sell
4,576
-52
-1% -$4.11K 0.04% 109
2023
Q2
$378K Buy
4,628
+1,144
+33% +$92K 0.05% 97
2023
Q1
$258K Sell
3,484
-1,040
-23% -$80.2K 0.04% 104
2022
Q4
$375K Buy
4,524
+364
+9% +$28.9K 0.06% 58
2022
Q3
$295K Buy
4,160
+1,300
+45% +$112K 0.03% 64
2022
Q2
$248K Buy
2,860
+572
+25% +$53.6K 0.01% 68
2022
Q1
$248K Buy
+2,288
New +$236K 0.01% 81

Other funds holding TECH

Simplify Asset Management's TECH Position: Q4 2024 in Review

Simplify Asset Management sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 7,618 shares — an estimated $609K sold.

Simplify Asset Management first reported a position in TECH in Q1 2022 and held it in 11 quarters. The position peaked at $644K in Q1 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

  • Simplify Asset Management reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
  • Simplify Asset Management sold 7,618 Bio-Techne shares in Q4 2024, an estimated $609K.
  • Simplify Asset Management first reported a position in Bio-Techne in Q1 2022 and held it in 11 quarters.
  • Simplify Asset Management's Bio-Techne position peaked at $644K in Q1 2024.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.